Michael O’Brien

Michael has experience across numerous therapeutic areas, including oncology, rare disease, metabolic disease, infectious disease/vaccines, gene therapy, neuroscience, mental health, cardiovascular, health tech, and autoimmune, among others. He’s led product communications programs ranging from early stage to product launch and beyond. Michael’s client experience includes: AstraZeneca, BMS, Pfizer, Pfizer Animal Health (now Zoetis), Teva, REGENXBIO, Sanofi/Genzyme, Intuitive Surgical, AARP, American Liver Foundation, American Association of Clinical Endocrinologists, NIH, ACOG, and NAMI.

Passionate about translating science and innovation to affect behavior change, Michael and his teams have earned more than 140 industry awards. Michael was nominated as the Most Purposeful Agency Pro for the inaugural PRWeek Purpose Awards.

Prior to joining ICR/Westwicke, Michael served as Vice President of Corporate Communications at the University of Maryland Medical System, as the Managing Director at JPA Health, and as the Global Head of Corporate Communications for MedImmune (biologics arm of AstraZeneca), among other healthcare agency and in-house positions.